Welltower (WELL)
(Delayed Data from NYSE)
$107.41 USD
+1.46 (1.38%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $108.00 +0.59 (0.55%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
WELL 107.41 +1.46(1.38%)
Will WELL be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for WELL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WELL
What's in the Cards for Healthpeak (DOC) This Earnings Season?
Alexandria (ARE) to Post Q2 Earnings: What's in the Cards?
WELL: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's in Store for Crown Castle (CCI) This Earnings Season?
Key Factors to Impact Prologis (PLD) This Earnings Season
Welltower's (WELL) Stock Rises 18.1% YTD: Will the Trend Last?
Other News for WELL
Real estate stocks gain as traders look for alternatives to tech stocks
WELL March 2025 Options Begin Trading
Haywood Sticks to Its Buy Rating for WELL Health Technologies Corp (WELL)
$1000 Invested In Welltower 20 Years Ago Would Be Worth This Much Today
WELL Health Launches its AI-POWERED Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease